Astera Labs, Inc. Common Stock (NASDAQ: ALAB) is a Technology company (Semiconductors) with a market capitalization of $35.4B. The Maz Rating grades it against the other companies in its sector.
Astera Labs, Inc. Common Stock's current Maz Rating and its five factor grades are for members: log in to see them.
At $202.34, Astera Labs, Inc. Common Stock trades at 75.5x trailing earnings, 22.7x sales and 17.6x book value, with an EV/EBITDA of 79.1. Over the last twelve months it generated about $1.6B of revenue and $468M of net income. It runs a gross margin of 73.9%, an operating margin of 25.5% and a net margin of 29.6%. It shows return on equity of 28.0%, return on invested capital of 19.3% and a free cash flow yield of 1.0%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 8.03. Over the past 52 weeks the share price ranged from $97.89 to $499.48, with a beta of 3.86.
Astera Labs, Inc. Common Stock does not currently pay a dividend.
18 Wall Street analyst ratings cover the stock: 13 Buy and 5 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Astera Labs, Inc. develops, produces, and markets semiconductor-based connectivity solutions for cloud computing and artificial intelligence infrastructure. Its core offering, the Intelligent Connectivity Platform, comprises a comprehensive portfolio of data, network, and memory connectivity products. These are unified by a software-defined architecture, which empowers customers to seamlessly deploy and operate high-performance cloud and AI systems at scale. Established in 2017, the company is headquartered in Santa Clara, California.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Astera Labs, Inc. Common Stock (ALAB) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones Islamic, and fails MSCI and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 0.00% / 30% · (Cash+Inv) / Mkt Cap (36m) 2.75% / 30% · Interest income / Revenue 2.22% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 0.00% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 2.75% / 33% · Receivables / Mkt Cap (36m) 0.57% / 49% · Interest income / Revenue 2.22% / 5% | Pass |
| Dow Jones Islamic | Debt / Mkt Cap (24m) 0.00% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 2.75% / 33.33% · Receivables / Mkt Cap (24m) 0.57% / 33.33% · Interest income / Revenue 2.22% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 0.08% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 67.4% / 33.33% · Receivables / Avg Assets (4Q) 9.36% / 33.33% · Interest income / Revenue 2.22% / 5% | Fail |
| FTSE | Debt / Total Assets 0.00% / 33.33% · (Cash+ST Inv) / Total Assets 59.9% / 33.33% · (Cash+Recv) / Total Assets 72.3% / 33.33% · Interest income / Revenue 2.22% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Astera Labs, Inc. Common Stock (ALAB) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones Islamic, and fails MSCI and FTSE.
Yes. Astera Labs, Inc. Common Stock is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 2.22% of each dividend: Astera Labs, Inc. Common Stock's interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal tech stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.